Catalent (CTLT) Tops Q2 EPS by 8c, Revenues Beat; Raises FY21 Revenue Guidance Above Consensus

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/25/2026

1. RNG
2. DECK
3. WDC
4. BMY
5. BYD
6. SPOT
7. WCN
8. TSCO
9. BE
10. SPY

Go back to Catalent (CTLT) Tops Q2 EPS by 8c, Revenues Beat; Raises FY21 Revenue Guidance Above Consensus

Catalent, Inc. Reports Second Quarter Fiscal 2021 Results

February 2, 2021 7:15 AM EST

Q2'21 net revenue of $910.8 million increased 26% as-reported, or 24% in constant currency, compared to Q2'20. Organic, constant currency net revenue grew 17%, compared to Q2'20. Q2'21 net earnings of $88.4 million increased 94%, or 88% in constant currency, compared to Q2'20. Q2'21 Adjusted EBITDA of $223.5 million increased 31% as-reported, or 28% in constant currency, compared to Q2'20. Q2'21 Biologics segment net revenue of $403.9 million increased more than 75%, compared to Q2'20. Increasing guidance to reflect projected net revenue... More